Literature DB >> 17720724

Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus.

A H Sawalha1, K M Kaufman, J A Kelly, A J Adler, T Aberle, J Kilpatrick, E K Wakeland, Q-Z Li, A E Wandstrat, D R Karp, J A James, J T Merrill, P Lipsky, J B Harley.   

Abstract

OBJECTIVE: The aetiology of systemic lupus erythematosus (SLE) is incompletely understood. Both genetic and environmental factors are implicated in the pathogenesis of the disease. Herein, we describe genetic association between SLE and polymorphisms in the interleukin (IL)-21 gene. The reported effect of IL-21 on B-cell differentiation into plasma cells and its effect on dendritic cell maturation and T-cell responses make IL-21 an attractive candidate gene for SLE.
METHODS: Three single nucleotide polymorphisms (SNPs) in the IL-21 gene were genotyped in a total of 2636 individuals (1318 cases and 1318 controls matched for age, sex and race). Population-based case-control association analyses were performed.
RESULTS: We found a genetic association with SLE and two SNPs located within the IL-21 gene (rs907715: chi(2) = 11.55, p<0.001; rs2221903: chi(2) = 5.49, p = 0.019). Furthermore, genotypes homozygous for the risk alleles were more frequent than genotypes homozygous for the non-risk alleles in European-American patients as compared to controls (rs907715 (GG versus AA): odds ratio (OR) = 1.66, p = 0.0049; rs2221903 (GG versus AA): OR = 1.60, p = 0.025).
CONCLUSION: Our findings indicate that IL-21 polymorphism is a candidate association with SLE. The functional effects of this association, when revealed, might improve our understanding of the disease and provide new therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17720724     DOI: 10.1136/ard.2007.075424

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  83 in total

Review 1.  Averting inflammation by targeting the cytokine environment.

Authors:  Manfred Kopf; Martin F Bachmann; Benjamin J Marsland
Journal:  Nat Rev Drug Discov       Date:  2010-09       Impact factor: 84.694

Review 2.  Understanding the development and function of T follicular helper cells.

Authors:  Roza I Nurieva; Yeonseok Chung
Journal:  Cell Mol Immunol       Date:  2010-04-12       Impact factor: 11.530

3.  Confirmation of an association between rs6822844 at the Il2-Il21 region and multiple autoimmune diseases: evidence of a general susceptibility locus.

Authors:  Amit K Maiti; Xana Kim-Howard; Parvathi Viswanathan; Laura Guillén; Adriana Rojas-Villarraga; Harshal Deshmukh; Haner Direskeneli; Güher Saruhan-Direskeneli; Carlos Cañas; Gabriel J Tobön; Amr H Sawalha; Alejandra C Cherñavsky; Juan-Manuel Anaya; Swapan K Nath
Journal:  Arthritis Rheum       Date:  2010-02

Review 4.  B cells as therapeutic targets in SLE.

Authors:  Iñaki Sanz; F Eun-Hyung Lee
Journal:  Nat Rev Rheumatol       Date:  2010-06       Impact factor: 20.543

5.  IL-21 promotes lupus-like disease in chronic graft-versus-host disease through both CD4 T cell- and B cell-intrinsic mechanisms.

Authors:  Vinh Nguyen; Irina Luzina; Horea Rus; Cosmin Tegla; Ching Chen; Violeta Rus
Journal:  J Immunol       Date:  2012-06-20       Impact factor: 5.422

6.  Interleukin-21, a potential diagnostic and therapeutic target for systemic lupus erythematosus.

Authors:  Yong He; Cheng Huang; Lei Zhang; Xiong-Wen Lv; Jun Li
Journal:  Rheumatol Int       Date:  2013-09-08       Impact factor: 2.631

7.  Investigation of IL-21 gene polymorphisms (rs2221903, rs2055979) in cases with multiple sclerosis of Azerbaijan, Northwest Iran.

Authors:  Tohid Gharibi; Tohid Kazemi; Mohammad Reza Aliparasti; Mehdi Farhoudi; Shohreh Almasi; Rashedeh Dehghanzadeh; Narges Seyfizadeh; Zohreh Babaloo
Journal:  Am J Clin Exp Immunol       Date:  2015-07-05

8.  Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity.

Authors:  C K Wong; Purple T Y Wong; L S Tam; Edmund K Li; D P Chen; Christopher W K Lam
Journal:  J Clin Immunol       Date:  2009-09-23       Impact factor: 8.317

9.  Decreased serum level of IL-21 in new-onset systemic lupus erythematosus patients.

Authors:  Hai-Feng Pan; Guo-Cui Wu; Yin-Guang Fan; Rui-Xue Leng; Hui Peng; Mo Zhou; Bao-Zhu Li; Yan Zhu; Jin-Hui Tao; Xiang-Pei Li; Dong-Qing Ye
Journal:  Rheumatol Int       Date:  2013-03-29       Impact factor: 2.631

Review 10.  New insights into the pathogenesis and genetics of psoriatic arthritis.

Authors:  Kristine E Nograles; Richard D Brasington; Anne M Bowcock
Journal:  Nat Clin Pract Rheumatol       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.